URGN   $17.62  -5.22% Market Closed After Close 17.8 1.02%

UroGen Pharma Ltd.
Total Cash 241.08M
totalCashPerShare 5.724
EBITDA -78.62M
Total Debt 99.03M
quickRatio 7.553
currentRatio 8.151
Total Revenue 85.01M
debtToEquity 326.694
Revenue/Share 2.45
ROA -0.26240999
ROE
grossProfits
freeCashflow -40.72M
operatingCashflow -85.78M
earningsGrowth
revenueGrowth 0.034
grossMargins 0.89872
ebitdaMargins -0.92481005
operatingMargins -1.18267
profitMargins -1.3361099
enterpriseValue 372.17M
forwardPE -4.450909
floatShares 24.44M
sharesOutstanding 42.11M
sharesShort 6.49M
sharesShortPriorMonth 6.37M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.94%
Short Ratio help_outline 9.01%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 0.736
Price To Book help_outline 16.63
earningsQuarterlyGrowth
netIncomeToCommon -113.58M
trailingEps -3.09%
forwardEps -2.75%
enterpriseToEbitda -4.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.82 3Q 2024
institutionsCount 168
lastUpdated Nov. 7, 2024, 2:38 a.m.